Home > Leads > Defibrillation
6947 Sprint Quattro Secure |
|
|
Product Characteristics |
| US Market Release |
Nov-01 |
|
Serial Number Prefix |
TDG |
| Registered US Implants |
206,100 |
|
Type and/or Fixation |
Transvenous, Vent, Defib and
Pace/Sense, Screw-in |
| Estimated Active US Implants |
151,200 |
|
Polarity |
True Bipolar/Two Coils |
| Advisories |
None |
|
Steroid |
Yes |
| System Longevity Study Results |
|
| US Returned Product Analysis |
| Implant Damage |
476 |
| Electrical Malfunction |
137 |
| Other |
25 |
|
| Number of Leads Enrolled in Study |
1,397 |
| Cumulative Months of Follow-Up |
54,528 |
| Number of Leads Active in Study |
597 |
| |
|
|
| Qualifying Complications |
23 Total |
|
| Conductor Fracture |
3 |
|
| Failure to Sense |
2 |
|
| Impedance Out of Range |
4 |
|
| Insulation (not further defined) |
2 |
|
| Lead Dislodgement |
3 |
|
| Oversensing |
7 |
|
| Unspecified Clinical Failure |
2 |
|
| |
|
|
| |
|
|
